IOVANCE BIOTHERAPEUTICS INC (IOVA)
US4622601007 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 164.19M | 114.89M | 231.70M | 78.20M | 67.30M | |||
| Marketable Securities | 233.30M | 164.98M | 240.10M | 426.20M | 562.10M | |||
| Receivables | 55.77M | 151.00K | N/A | N/A | N/A | |||
| Inventories | 38.58M | 10.37M | N/A | N/A | N/A | |||
| Other Current Assets | 6.74M | 17.46M | 7.30M | 3.50M | 6.70M | |||
| Total Current Assets | 498.58M | 307.85M | 479.10M | 508.00M | 636.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 179.26M | 176.54M | 178.20M | 169.90M | 113.90M | |||
| Investments And Advances | N/A | N/A | 0.00 | 91.60M | N/A | |||
| Intangibles | 306.64M | 229.26M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 6.63M | 66.70M | 6.60M | 7.90M | 18.40M | |||
| Total Non-Current Assets | 492.54M | 472.50M | 184.90M | 269.30M | 132.40M | |||
| TOTAL ASSETS | 991.12M | 780.35M | 664.00M | 777.30M | 768.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 86.37M | 77.18M | 64.90M | 61.80M | 41.40M | |||
| Accounts Payable | 31.69M | 33.12M | 26.60M | 27.40M | 13.50M | |||
| Total Current Liabilities | 118.06M | 110.31M | 91.50M | 89.20M | 54.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.00M | 1.00M | 1.00M | 1.00M | 0.00 | |||
| Deferred Taxes/Income | 32.22M | 17.35M | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 66.39M | 67.08M | 71.90M | 65.50M | 57.10M | |||
| Total Non-Current Liabilities | 99.60M | 85.43M | 72.80M | 66.50M | 57.10M | |||
| TOTAL LIABILITIES | 217.66M | 195.74M | 164.30M | 155.70M | 112.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.31B | -2.01B | -1.57B | -1.17B | -830.20M | |||
| Additional Paid In Capital | 3.06B | 2.59B | 2.07B | 1.79B | 1.49B | |||
| Common Shares | 16.00K | 14.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 16.24M | 2.53M | -900.00K | -600.00K | 0.00 | |||
| Shares Outstanding | 304.62M | 256.14M | 187.80M | 157.00M | 146.90M | |||
| Tangible Book Value per Share | 1.53 | 1.39 | 2.66 | 3.96 | 4.47 | |||
| Total Shareholders' Equity | 773.46M | 584.61M | 499.60M | 621.70M | 656.50M | |||
| TOTAL LIABILITIES AND EQUITY | 991.12M | 780.35M | 664.00M | 777.30M | 768.50M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Current Ratio | 4.22 | 2.79 | 5.24 | 5.70 | 11.59 | |||
| Return On Assets (ROA) | -41.37% | -56.90% | -59.62% | -44.03% | -33.78% | |||
| Return On Equity (ROE) | -53.01% | -75.95% | -79.24% | -55.05% | -39.54% | |||
All data in USD , ROIC based on taxRate of 0.21